SCHEMBL6287967

SCHEMBL6287967

CC(C)(C)OC(=O)[C@@](C)(NC(=O)Cc1c[nH]c2ccccc12)C(=O)Nc1ccc(C(c2ccc(NC(=O)[C@](C)(NC(=O)Cc3c[nH]c4ccccc34)C(=O)OC(C)(C)C)cc2)c2ccc(NC(=O)[C@](C)(NC(=O)Cc3c[nH]c4ccccc34)C(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.47
HRH3 Q9Y5N1 3/20 0.47
ANO1 Q5XXA6 1/20 0.45
MAPT P10636 5/20 0.45
HDAC1 Q13547 3/20 0.44
PKM P14618 2/20 0.43
HTT P42858 2/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
TACR1 P25103 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GOT1 P17174 1/20 0.43
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 2/20 0.43
ALOX12 P18054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7037700 0.91 MAPT (0.49) ALDH1A1HRH3ANO1MAPTHDAC1
SCHEMBL7038485 0.83 HRH3 (0.48) ALDH1A1HRH3ANO1MAPTHDAC1
SCHEMBL7208646 0.80 L3MBTL1 (0.47) ALDH1A1HRH3ANO1MAPTPKM
SCHEMBL6287921 0.79 TACR1 (0.56) ALDH1A1MAPTHTTTACR1
SCHEMBL6287965 0.79 MAPT (0.48) ALDH1A1HRH3MAPTHDAC1HTT
SCHEMBL6287876 0.78 HRH3 (0.55) ALDH1A1HRH3MAPTHDAC1PKM
SCHEMBL6284051 0.77 TACR1 (0.53) MAPTHTTTACR1LMNA
SCHEMBL6287895 0.75 HRH3 (0.53) ALDH1A1HRH3MAPTHDAC1HTT
SCHEMBL6287996 0.74 CTSL (0.41) ALDH1A1MAPTHDAC1HTTTACR1
SCHEMBL18229441 0.74 HRH3 (0.65) ALDH1A1HRH3MAPTHDAC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887890-B2 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2005-05-03 US disclosed
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-08-28 US disclosed
EP-1291341-A1 COMPOUNDS EXHIBITING THROMBOPOIETIN-LIKE ACTIVITIES CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162724-A1 Compounds exhibiting thrombopoietin-like activities MPL, THPO, TEK ALDH1A1 2042/4885HRH3 2351/4885ANO1 1520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.